For patients with advanced or metastatic non-small cell lung cancer (NSCLC) and ...
The European Commission has approved the label expansion of Takeda’s Takhzyro (...
Oxurion has started to file for bankruptcy after the Phase IIb trial investigat...
Pfizer has entered a licence agreement with Serina Therapeutics for its drug de...
A team of researchers at Monash University in Australia will receive a $5m ...
AstraZeneca has launched Evenova, a new digital health solutions business, with...
Bayer has announced a voluntary recall of a single lot of its cancer therapy Vi...
The European Commission (EC) has granted marketing authorisation to BeiGene’s B...
The US Food and Drug Administration (FDA) awarded an orphan drug designation to...
Chiesi Group and Haisco Pharmaceutical have entered a licence agreement to join...
A number of stories in the UK have emerged around Novo Nordisk’s blockbuster we...
Here are some key questions (and answers) about the historic approval of a CRISP...
CRISPR’s pioneers reflect on the first gene-editing treatment: It’s a symbol of ...
Letters to the Editor: What STAT readers think about recent articles on premed r...
When we point at an object, the toddler focuses on the object, while the dog usu...
Merck & Co. is racing against the clock to launch the first medication for chron...
